Brinzolamide Suspension/ Drops
Product Images NDC 24208-464

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Brinzolamide (NDC 24208-464). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bausch & Lomb Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemstructure (Image 01)

Chemical structure diagram of brinzolamide, the active ingredient in BRINZOLAMIDE ophthalmic suspension 10 mg/mL by Bausch & Lomb Incorporated.*

FDA Label Image

Carton10ml (Image 02)

Packaging label for Brinzolamide Ophthalmic Suspension USP 1%, a 10 mL eye drop suspension by Bausch & Lomb Incorporated. The label includes drug strength, usage instructions, storage information, active and inactive ingredients, and various warnings including to keep out of reach of children and not to use if the neckband is broken.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.